Evidence map›Paper›PMID 25972363›Full record

ArticleOncotarget2015

DNA strand breaks induced by nuclear hijacking of neuronal NOS as an anti-cancer effect of 2-methoxyestradiol.

Magdalena Gorska, Alicja Kuban-Jankowska, Michal Zmijewski, Antonella Marino Gammazza, Francesco Cappello, Maciej Wnuk, Monika Gorzynik, Iwona Rzeszutek, Agnieszka Daca, Anna Lewinska and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Magdalena GorskaDepartment of Medical Chemistry, Medical University of Gdansk, Gdansk, Poland.
Alicja Kuban-JankowskaDepartment of Medical Chemistry, Medical University of Gdansk, Gdansk, Poland.
Michal ZmijewskiDepartment of Histology, Medical University of Gdansk, Gdansk, Poland.
Antonella Marino GammazzaDepartment of Experimental Biomedicine and Clinical Neurosciences, Section of Human Anatomy ''Emerico Luna'', University of Palermo, Palermo, Italy.
Francesco CappelloDepartment of Experimental Biomedicine and Clinical Neurosciences, Section of Human Anatomy ''Emerico Luna'', University of Palermo, Palermo, Italy.
Maciej WnukDepartment of Genetics, University of Rzeszow, Rzeszow, Poland.
Monika GorzynikDepartment of Medical Chemistry, Medical University of Gdansk, Gdansk, Poland.
Iwona RzeszutekDepartment of Genetics, University of Rzeszow, Rzeszow, Poland.
Agnieszka DacaDepartment of Pathophysiology, Medical University of Gdansk, Gdansk, Poland.
Anna LewinskaDepartment of Biochemistry and Cell Biology, University of Rzeszow, Rzeszow, Poland.
Michal WozniakDepartment of Medical Chemistry, Medical University of Gdansk, Gdansk, Poland.
Gdańsk Medical University · PLRzeszów University · PLIstituto Euro Mediterraneo di Scienza e Tecnologia · ITUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

2-Methoxyestradiol (2-ME) is a physiological metabolite of 17β-estradiol. At pharmacological concentrations, 2-ME inhibits colon, breast and lung cancer in tumor models. Here we investigated the effect of physiologically relevant concentrations of 2-ME in osteosarcoma cell model. We demonstrated that 2-ME increased nuclear localization of neuronal nitric oxide synthase, resulting in nitro-oxidative DNA damage. This in turn caused cell cycle arrest and apoptosis in osteosarcoma cells. We suggest that 2-ME is a naturally occurring hormone with potential anti-cancer properties.

Indexed as

2-MethoxyestradiolAntineoplastic AgentsApoptosisBone NeoplasmsCell Line, TumorCytokinesisDNA BreaksEstradiolG2 Phase Cell Cycle CheckpointsHumansIntracellular Signaling Peptides and ProteinsM Phase Cell Cycle CheckpointsNitric OxideNitric Oxide Synthase Type IOsteosarcomaOxidative Stress2-MethoxyestradiolAntineoplastic AgentsEstradiolIntracellular Signaling Peptides and ProteinsNitric OxideNitric Oxide Synthase Type IReactive Nitrogen SpeciesTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 12-methoxyestradiolneuronal nitric oxide synthasenitric oxideosteosarcomareactive nitrogen species

Identifiers

PMID25972363
PMCPMC4558163
OpenAlexW1873667577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.